Zhitong Finance APP Newssimpsonsarcademachine, Hengrui Pharmaceutical (600276simpsonsarcademachine.SH) Announcementsimpsonsarcademachine, SHR-A1921 for injection from the company's subsidiary Suzhou Shengdiya Biomedical Co., Ltd. is planned to be included in the publicity list of breakthrough treatment varieties by the Center for Drug Evaluation of the State Food and Drug Administration, with a publicity period of 7 days. Proposed indication (or functional indications) of this drug: It is used to treat platinum-resistant recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.
simpsonsarcademachine| Hengrui Pharmaceutical (600276.SH): Subsidiary SHR-A1921 for injection is expected to be included in the public list of breakthrough treatment varieties
- Hot
-
- doubledoublepoker| Boeing's annual safety report: Safety and quality concerns raised by employees surged more than 500% in the first two months of this year
- playbigbassbonanzafree| Evergrande Automobile: 3.145 billion shares are pending acquisition, and trading is about to resume
- 25freespinsforregistration| Zero Point Number (301169.SZ): Some independent directors cannot guarantee the authenticity, accuracy and completeness of regular reports
- earnrealcryptoplayinggames| Payment and Clearing Association: Acquisition outsourcing service institutions should complete filing before July 31
- roulettegameforfun| Jinmo Technology (300334.SZ): Terminate the issuance of shares to specific objects through summary procedures in 2023
- caesarslotsfreecoinsdaily| Analysis of market dynamics that investors pay attention to: Investor behavior and market trends
- reczonevideopoker| Shandong's first Sam's Club store officially settled in Qingdao
- baccarat200ml| Big news! Apple and OpenAI have reached a partnership, and iOS 18 will introduce generative AI capabilities
- superslots| Dekeli (688205.SH)2023 annual equity distribution: 0.30 yuan per share increased to 0.2 shares May 30 equity registration
- fpnpoker| Huichang Communications (300578.SZ): Net loss in 2023 is 501 million yuan
- 5jili com
-